Author Correction: The biological significance of histone modifiers in multiple myeloma: clinical applications

Blood Cancer J. 2021 Oct 6;11(10):165. doi: 10.1038/s41408-021-00559-4.

Hiroto Ohguchi^{1

2}, Teru Hideshima³, Kenneth C Anderson⁴

¹ Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. ohguchi@kumamoto-u.ac.jp.
² Division of Disease Epigenetics, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan. ohguchi@kumamoto-u.ac.jp.
³ Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
⁴ Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Kenneth_Anderson@dfci.harvard.edu.

No abstract available

Publication types